KRYSTAL BIOTECH INC (KRYS) Stock Income Statement
USA - NASDAQ:KRYS - US5011471027 - Common Stock
204.1 USD
-0.64 (-0.31%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 373.16M | 290.51M | 50.70M | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 21.41M | 20.06M | 3.09M | null | null | |||
| Gross Profit | 351.76M | 270.45M | 47.60M | null | null | |||
| Operating Expenses | 193.52M | 167.26M | 144.83M | 120.20M | 68.28M | |||
| Research and Development | 56.77M | 53.57M | 46.43M | 42.46M | 27.88M | |||
| Selling, General, and Administrative Expenses | 136.75M | 113.69M | 98.40M | 77.74M | 40.39M | |||
| Operating Income | 158.24M | 103.19M | -97.23M | -120.20M | -68.28M | |||
| Interest Income/Expense | 28.71M | 29.66M | 22.62M | 5.22M | -1.30M | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | 0 | -37.50M | 87.50M | -25.00M | null | |||
| Income Before Taxes | 186.95M | 95.36M | 12.90M | -139.98M | -69.57M | |||
| Income Tax | -11.96M | 6.20M | 1.97M | null | null | |||
| Net Income | 198.91M | 89.16M | 10.93M | -139.98M | -69.57M | |||
| EBITDA | 163.21M | 109.16M | -92.22M | -116.14M | -65.51M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 6.6635 | 2.998 | 0.3939 | -5.49 | -3.13 | |||
| Non GAAP EPS | 6.67 | 2.9899999999999998 | -3.4 | -4.51 | -3.0599999999999996 | |||
| Statistics | ||||||||
| Gross Profit Margin | 94.26% | 93.09% | 93.90% | N/A | N/A | |||
| Profit Margin | 53.30% | 30.69% | 21.56% | N/A | N/A | |||
| Operating Profit Margin | 42.40% | 35.52% | -191.77% | N/A | N/A | |||
All data in USD